• Login
  • Get started
aescuvest.eu
  • Invest
    • Investment opportunities
    • Private investors:
      The Aescuvest Model
    • Institutional investors:
      10x Health Investment Club
    • FAQ
    • Glossary
  • Raise Funds
  • More
    • About aescuvest
    • About EIT Health
    • Aescuvest Team
    • Alumni
    • Investment Committee
    • Advisory Board
    • Careers
    • Blog
    • Content Hub
    • Contact
  • Invest
    • Investment opportunities
    • Private investors:
      The Aescuvest Model
    • Institutional investors:
      10x Health Investment Club
    • FAQ
    • Glossary
  • Raise Funds
  • More
    • About aescuvest
    • About EIT Health
    • Aescuvest Team
    • Alumni
    • Investment Committee
    • Advisory Board
    • Careers
    • Blog
    • Content Hub
    • Contact
  • Login
  • Get started
  • eu-icon EU de-icon DE

    • This service is offered to you on the independent platform aescuvest.de by aescuvest GmbH.

    On aescuvest.de you can grant loans to companies from the German healthcare market.

    By clicking on "I agree" you leave the website of aescuvest International GmbH.

    I agree

Sign up with

  • Sign up with Facebook
  • Sign up with Google
  • Sign up with LinkedIn
  • Sign up with Twitter


or


For information about how we use your personal data please see our Privacy Statement.

Already have an account? Login

aescuvest enables great health innovations through equity investments. It is the leading platform to foster and fund smart healthcare ideas. This independent launch pad offers financing strategies to companies & an above-average profit share to investors.

EIT Health is one of the largest healthcare initatives wordwide. Its goal is to sustainably advance the fundamentals of healthcare and thus promote suitable future conditions for healthy living, active ageing and improved wellbeing of people across Europe.

About us

  • About aescuvest
  • About EIT Health
  • Aescuvest Team
  • Alumni
  • Investment Committee
  • Advisory Board
  • Careers
  • Blog
  • Content Hub
  • Contact

Stay tuned

Follow us on

Subscribe to our newsletter

By clicking on 'Sign up', you agree to receive the newsletter with information on, for example, our services, our company as well as to its analysis through individual measurement, storage and evaluation of opening rates and click rates in recipient profiles for the purpose of designing future newsletters according to the interests of our readers. Consent can be revoked with effect for the future. Detailed information is available in our data privacy terms.

For investors

  • Private investors:
    The Aescuvest model

  • Institutional investors:
    10x Health Investment Club

For idea providers

Apply now

How to

  • FAQ
  • Glossary
  • aescuvest partner program

Help & legal

  • Data privacy
  • Legal notice
  • Contact

Powered by our partners

Crowddesk – excellence in crowdfinance
www.crowddesk.de

European crowdfunding network
www.eurocrowd.org

Past legal documents

Endoscopy Innovations Invest GmbH & Co. KG

Legal notices

Published securities prospectuses

ABS prospectus – Diabetes Care Innovations Investment GmbH & Co. KG, dated September 10, 2020 | PDF | 3 MB
Prospectus summeries – English | Danish | Swedish

First Supplement to ABS Prospectus_Diabetes Care Innovations Investment GmbH & Co. KG, dated October 27, 2020 | PDF | 4 MB

Risk warning

The acquisition of the offered securities is associated with considerable risks and can lead to the complete loss of the invested assets. The expected yield is not guaranteed and may be lower.

Liability umbrella

Investment advice according to section 1 para. 1a no. 1a German Banking Act (Kreditwesengesetz) and investment brokerage according to section 1 para. 1a no. 1 German Banking Act (Kreditwesengesetz) shall be made on behalf of, in the name of, for the account and under the liability of the responsible legal entity BN & Partners Capital AG, according to section 2 para. 10 German Banking Act (Kreditwesengesetz). BN & Partners Capital AG has a corresponding license from the German Federal Financial Supervisory Authority (BaFin) in accordance with section 32 KWG for the prenamed financial services.